Osiris makes Lode Debrabandere COO
This article was originally published in Clinica
Osiris Therapeutics, a stem cell company focusing on the research, development, manufacturing and distribution of stem cell products, has appointed Dr Lode Debrabandere COO. Dr Debrabandere has been with the company since 2006, having most recently served as senior vice-president for Therapeutics. Prior to that, Mr Debrabandere served as vice-president of global marketing at Bristol-Myers Squibb.